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ABSTRACT 
Introduction: Delirium research in palliative care, particularly in the dying phase, is possible but is 
frequently met with ethical and methodological challenges. This paper describes the challenges 
faced in a previous delirium screening study. 
Methods: Within 72 hours of admission to an acute inpatient specialist palliative care unit one 
hundred consecutive patients over 18 years of age with advanced cancer were invited to be 
screened for delirium using validated screening tools. 
Results: Of the 100 consecutive admissions 49 patients were unable to participate including seven 
who did not meet the inclusion criteria and nine (six families and three patients) who withheld 
consent. The remaining 33 patients were more unwell and closer to death than those who were 
recruited. Reasons for non- participation included being too unwell (ten), unresponsive (nine), died 
(two) or discharged (three) before recruitment and exceeding the 72hour time limit (nine). 
Conclusion: Gate keeping and physical condition of patients were the main obstacles to recruitment 
and is consistent with barriers faced in previous studies involving palliative care and dying patients. 
While it is possible and necessary to conduct studies in palliative care, including the terminal phase, 
as reflective practitioners we must maintain the balance between the demands for evidence-based 
practice and our compassion and respect for our most vulnerable of patients. 
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Challenges of recruiting hospice inpatients with advanced cancer 
to research: reflections on a delirium screening study. 
Introduction 
        A recent editorial by Sheila Payne1 challenges palliative care professionals to continue 
to question, debate and reflect on the ‘ethical, practical and methodological dilemmas’ of 
recruiting palliative care patients to research studies.  In essence it is finding the balance 
between the science and the art of caring. 
        Studies undertaken in palliative care, including inpatient hospice settings, aim to 
establish evidence-based practice to improve the quality of life of patients and the care-
giving experience however, researchers face numerous challenges.2, 3 Obtaining informed 
consent from very ill patients can be ethically and legally challenging but possible.4  While a 
systematic review by White and Hardy5 suggests that patients with life limiting illnesses are 
willing to participate in research, the ethics of recruiting such patients, especially those who 
are very ill or in the terminal phase, remains contentious6. Historically patients in the terminal 
phase have been considered too vulnerable, too unwell, too exhausted or with limited 
cognitive ability to provide informed consent to participate. Thus health care professionals 
often act as ‘gatekeepers’ excluding these patients in the belief they would find any request 
to participate as intrusive as they have little to gain personally from the findings and 
therefore need protecting.7,8  
        Ethics9 is not the only barrier to recruiting palliative care patients as methodological and 
logistical factors can impede recruitment. The disease trajectory of palliative care patients 
frequently presents with complex symptoms, which can include extreme mental and physical 
fatigue, and poor performance status which creates its own challenges. Of those who do 
consent to participate in research trials patient attrition10 becomes an obstacle  as patients 
often die or become too unwell to continue in studies. The difficulties of recruitment and 
attrition frequently results in small sample size,11  recruitment of subpopulations  and 
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selection and missing data12 biases, particularly in the dying patient cohort,13 that questions 
the generalizability of results. Despite these barriers conducting research in palliative care is 
feasible14 especially if strategies are implemented to ameliorate these problems during the 
development phase of a research study.7,15  
        Delirium studies at end-of-life can be particularly challenging as decision-making 
capacity can be impaired. Fluctuation and subjectivity of symptoms can make delirium, 
especially the hypoactive subtype16, difficult to recognise17and while screening increases 
detection currently there is no consensus as to the best tool to use.18,19  A previous delirium 
screening study by the authors20 found nearly half of the targeted patients either declined to 
participate or were excluded due to their physical condition. This paper reflects on the 
challenges encountered and while the barriers were not unique to this study to the authors’ 
knowledge there are limited papers specifically describing the challenges of recruiting 
patients with advanced cancer to delirium studies.  
 
Description of the delirium screening study 
        The aim of the study was to determine the prevalence of delirium within 72hours of 
admission to a 19-bed acute specialist inpatient hospice (363 admissions in 2013; 83% with 
a malignant diagnosis; average stay 18.2 days; median stay 11 days) in Canberra, Australia 
(population 383,40021), in patients with advanced cancer and to determine if the use of a 
validated screening tool increased the recognition of delirium.  
        Two validated tools were chosen, (1)the Delirium Rating Scale: Revised 1998 (DRS-
R98)22 requiring patient participation for at least 15- 20 minutes and (2)the Confusion 
Assessment Method shortened diagnostic algorithm (CAM)23 taking less than five minutes to 
complete by either the patient or carer. The longer tool has the advantage of classifying 
patients into hyperactive, hypoactive or subclinical delirium potentially tailoring management 
to improve patient care. 
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        Between February and June 2013 one hundred consecutive patients over 18years of 
age with advanced cancer admitted to the inpatient hospice were considered for 
participation in the study.  Within 72 hours of admission, the one investigator approached the 
patient and/or their family informing them of the study and inviting them to be screened for 
delirium. Written consent from the patient, or their proxy (enduring power of attorney or next 
of kin as identified on admission records) where the patient was not capable of providing 
consent due to cognitive impairment, was gained from 51patients. Consenting patients were 
screened for delirium using the  DRS-R-98 and CAM. The investigator then carried out a 
review of the medical charts of participating patients to determine the rate of delirium 
recognition by the treating team prior to screening, based on DSM-IV24 criteria.    
        While it may have been possible to screen the patients as part of routine clinical 
practice and then conduct a quality improvement audit, to comply with the policies and 
procedures of the hospice Human Research Ethics Approval was obtained. This had the 
benefit of engaging the onsite palliative care research centre and carrying out the study 
under research conditions using two validated tools. Non-English speaking patients and 
those with dementia or co-morbid psychiatric disorder were excluded.  
        Data were collected on patient demographics and screening scores, entered into  
SPSS-20 and summarized using descriptive statistics including means, standard deviations, 
ranges and frequencies. The investigator, a palliative care medical officer who at the time 
was not part of the treating team, made a descriptive record of the difficulties faced with 
individual patients. 
 
Results 
           The remainder of this paper focuses on the challenges of recruiting inpatient hospice 
care patients with advanced cancer to a delirium screening study. Having previously worked 
in the inpatient unit the authors felt they were familiar with the staff and general 
characteristics of the patients so recruiting  patients seemed achievable however,  of the 100 
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consecutive advanced cancer admissions 51 patients agreed to participate. Of the remaining 
49 admissions seven did not meet the inclusion criteria, nine withheld consent (six patients 
and three families) and 33 did not participate for reasons shown in Figure1. These 33 
patients were more unwell and closer to death than those who participated; mean age 65.2 
years (SD 16.9; range 30-95); 16 (48%) were female. (Table 1)  
        The reasons given by the treating team that the patient was too unwell to be screened 
included uncontrolled symptoms such as pain, nausea and breathlessness.  On two 
occasions the nursing staff requested the investigator not approach the patient as they were 
very unwell and the family was distressed. The investigator also made the decision not to 
disturb two very frail sleeping patients. According to the treating team none of the above four 
patients had a recognisable delirium and unfortunately there was no further opportunity to 
screen them within 72 hours of their admission. Of the remaining six patients considered too 
unwell to participate three potentially had a diagnosis of delirium according to the treating 
team.  
 
INSERT FIGURE 1 ABOUT HERE 
 
INSERT TABLE 1 ABOUT HERE 
 
        The reasons given for withholding consent included “I’m not interested”, “No thanks, I 
don’t have a delirium. I’m not confused.”, “My Dad’s too tired today” and “I’ve just arrived 
please come back tomorrow”. The latter two refusals occurred at the end of the week 
meaning it was not possible to return and screen the patients within 72hours of admission. 
With the exception of one family who was angry by our request to participate, most families 
were apologetic their family member could not participate.  
        On three occasions where recruitment to the study was not possible due to the physical 
condition of the patient the family requested to participate. While the DRS-R-98 was unable 
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to be used completion of the CAM by the family and medical record audit showed a positive 
result for delirium for all three patients in the preceding 24 hours. These findings influenced 
subsequent medical care and treatment planning but were excluded from the final analysis 
as both screening tools were not applied.  
 
Discussion 
       Despite this study having strategies recommended in the literature7 including ethics 
approval, managerial support, onsite research centre support and collaboration with hospice 
staff (nursing and medical) there were still challenges in accessing and recruiting hospice 
inpatients. This paper highlights the challenges experienced with findings consistent with 
barriers encountered in most care of the dying research.15,25 Four categories, not necessarily 
mutually exclusive,  were  identified including (1) methodological and logistical issues, (2) 
patient characteristics, (3) ‘gatekeeping’ and (4) ethical issues.   
        In an effort to reduce the burden on medical and nursing staff the one investigator 
carried out recruitment and assessment of all the patients. Whilst this increased the 
consistency in applying the screening tool it meant it was not possible, due to rostering and 
long weekends, to access all admissions within 72 hours. 
        The choice of screening tool was a factor in recruitment as illustrated by the families of 
the three non-recruited patients who requested to participate. While both tools used in this 
study had been validated for use in palliative care the use of the longer DRS-R-98 increased 
the participation burden potentially resulting in recruitment bias contributing to the high non-
participation rate and possible under estimation of the prevalence of delirium. 
      One of the key reasons for non-participation was the physical condition of the patient- 
clinical deterioration and high baseline symptom burden unrelated to the study. These 
reasons for non-participation are similar to the reasons given for high attrition rates in 
palliative oncology trials10 and are not surprising given the reasons for admission to inpatient 
hospice. 
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        Recruiting patients on or soon after hospice admission coincides with a time that is 
often overwhelming to the patient and their family and can be associated with high levels of 
distress. Following assessments by the nursing and medical teams the additional demands 
of the presence of an unknown investigator was sometimes perceived as ‘a disruption to the 
settling in process.’  Prior to approaching the patient the investigator gained permission from 
the treating team and on a number of occasions they acted as ‘gatekeeper’ stating the 
patient was too unwell, unresponsive or the patient and or family was too distressed to be 
disturbed. A systematic review by Rinck et al 26 advocated that in order to enhance the 
quality of palliative care trials patients with very limited life expectancy should be avoided.  
Whilst it could be argued that the unresponsive patients had nothing to gain by being 
involved in the study as they were close to death, the literature suggests that delirium is 
common in the terminal phase.18 However, if some of the ‘unresponsive’ patients had an 
unrecognised hypoactive delirium in the terminal phase screening may have resulted in an 
improvement in patient and family care by altering clinical management and providing 
valuable information to the family to enhance their understanding thereby reducing distress.  
     In some situations not being a member of the treating team created an objective distance 
on the part of the investigator however, there were times when the investigator was unable 
to remain detached. While aware of the possibility that some of the very unwell or distressed 
patients had a delirium and would benefit from recognition and implementation of a specific 
management plan on two occasions the investigator made the decision not to disturb frail 
sleeping patients. Lynch et al27 recognised the risk of the investigator distorting research 
aims and objectives by blurring the boundaries between research and therapeutic 
relationships. Whilst it is important to establish a relationship of trust between researcher 
and participant it is imperative not to take advantage of this trust through an imbalance in 
‘power.’ Whilst these vulnerable patients approaching the end of life need to be protected 
from undue distress, managing ‘gatekeeping’ reflects the importance of maintaining the 
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balance between conducting research that can benefit patients and minimising patient 
burden and distress.      
        In any research the ethics of consent must be maintained to ensure advantage is not 
taken of vulnerable patients, especially those with impaired cognitive capacity. Mindful that 
delirium is common in dementia28 and the screening tools used have a high specificity and 
sensitivity for delirium22,23 for ethical reasons and the paucity of published dementia studies 
in advanced cancer palliative care, the decision was made to preclude patients with a pre-
existing dementia. The literature suggests consent and capacity are major ethical challenges 
in palliative care delirium studies29 however obtaining informed consent in this study was not 
the main contributing factor for non-participation in eligible patients as in all cases where 
patients had reduced cognitive capacity their proxy (universally their next of kin) provided 
consent.  While the number of patients for which consent was withheld (9%) is consistent 
with a previous study by Gibbins et al14  (8%)  the generalizability of this finding is limited as 
many of the most vulnerable patients were not approached due to ‘gatekeeping’ and it is 
uncertain whether patient or proxy consent would have been obtained. 
        The challenges faced in recruitment and the use of a single site resulted in a number of 
limitations including a small sample size and recruitment bias. These limitations not only 
question the generalizability of the results to other settings but whether the findings of this 
study are representative of this inpatient hospice population due to non-participation of 
patient subgroups, however, this reflects the challenges inherent in recruiting patients to 
research at the end of life. The participation rate may have been increased by using more 
than one investigator and working more closely with the treating team to allay concerns 
regarding screening burden while reinforcing the clinical benefits to patient care. It is hoped 
this study adds to the literature informing future research including  consideration of 
interventional study design and multi centre research.   
        Despite the challenges encountered the aims of the study were achieved and the 
awareness of delirium was raised amongst the medical and nursing staff with subsequent 
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changes to current clinical practice. A process is underway to incorporate delirium screening 
into routine clinical care in this inpatient hospice unit. While there remains a lack of 
consensus regarding the choice of delirium screening tool this study supports the CAM as 
being appropriate. Future studies are recommended to determine if routine screening 
improves patient outcomes especially in the terminal phase.        
        In conclusion, whilst it is possible and necessary to conduct studies in palliative care 
including the terminal phase more work needs to be done to address the challenges of 
recruitment. The challenges encountered in this study were not specific to delirium but are 
consistent with the barriers faced in many studies involving palliative care and dying 
patients- ‘gatekeeping’ by health professionals and the disease trajectory of palliative care 
patients (frailty, rapid deterioration and death). Thought must be given in the development 
phase of research to develop strategies to engage the treating teams and maintain the 
balance between conducting research that can benefit patients while minimising patient 
burden and distress. 
        As reflective practitioners we must maintain the balance between the demands for 
evidence- based practice and our compassion and respect for our most vulnerable of 
patients and their carers. The authors hope this paper adds to the continuing debate of 
finding the balance between science and the art of caring. 
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FIGURE 1: FLOW CHART OF DELIRIUM SCREENING STUDY 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ineligible N=7 
Dementia n=4 
Non English speaking n=3 
100 consecutive admissions 
93 patients identified 
60 patients approached 
Gatekeeping by treating team N=17 
Too unwell n=4 
Unresponsive n=9 
Family distress n=2 
Sleeping/ not disturbed n=2 
76 potential patients Patients not approached N=16 
Died prior to screening n=2 
Discharged prior to screening n=3 
Unable to be approached within  
72hrs of admission n=9 
Asleep, not woken n=2 
51 patients screened 
Consent not gained N=9 
Withheld by patient n=6 
Withheld by proxy n=3 
22 patients screened positive for delirium on  
DRS-R-98 and/or CAM 
15 had delirium documented in medical notes 
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Table 1: Differences between participating and non-participating patients 
 Participating Patients. Non-participating patients  
N 51 33 
Age Mean= 70.8years 
(SD 13.7; range 32-92) 
Mean= 65.2years 
(SD 16.9; range 30-95) 
Male : Female  19(37%) : 32(63%) 17(52%) : 16(48%) 
Reason for admission   
        End of life care 19 (37%) 26 (79%) 
        Symptom  management 28 (55%)   7 (21%) 
        Respite   4 (8%)   - 
Death   
    Within 24hrs admission   -   6 (18%) 
    >24-48hrs   1 (2%)   2 (6%) 
    >48-72hrs   -   2 (6%) 
   >72hrs- 7days 13 (25%) 12 (36%) 
   >7days 27 (53%)   6 (18%) 
   Unknown-Discharged  10 (20%)   5 (16%) 
 
